# Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy

> **NCT06137612** · — · UNKNOWN · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 52 (estimated)

## Conditions studied

- Spinal Muscular Atrophy Type III
- Spinal Muscular Atrophy Type II

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT06137612
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-17
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-09-15
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137612, "Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06137612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*